Titanium 4000 Capsule (D.B.P. Distribution) – Undeclared Ingredients (2019)
Class I: A situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death
Class I recall indicates potential for serious health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000 UPC 86077000020
Brand
D.B.P. Distribution
Lot Codes / Batch Numbers
Expiration 12/29/2020
Products Sold
Expiration 12/29/2020
D.B.P. Distribution is recalling Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titan due to Marketed without an approved NDA/ANDA: undeclared sildenafil and tadalafil.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Marketed without an approved NDA/ANDA: undeclared sildenafil and tadalafil.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026